Trial Profile
A Phase II Trial of Avastin, Docetaxel and Androgen Deprivation Followed by Continued Avastin and Androgen Deprivation for Men With a Rising PSA After Local Therapy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Bicalutamide; Docetaxel; Goserelin; Leuprorelin
- Indications Prostate cancer
- Focus Therapeutic Use
- 25 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 19 Mar 2015 Planned End Date changed from 1 Dec 2014 to 1 Jun 2017as per ClinicalTrials.gov record.
- 01 Feb 2014 Results presented at the 2014 Genitourinary Cancers Symposium.